Klein Lab’s IllinoisVentures Award is Featured in Chicago Tribune and Crain’s Chicago Business
IllinoisVENTURES, a premier seed and early-stage technology investment firm focused on research-derived companies in information technologies, physical sciences, life sciences and clean technology, has funded the first five projects under a new proof-of-concept program called Regional Proof of Concept Matching Fund Program. William Klein, professor in neurobiology, is named one of the grant recipients for developing new imaging technology to detect Alzheimer's at an earlier stage. Klein’s award was featured in Chicago Tribune’s Blue Sky innovation edition where it discussed how IllinoisVentures is addressing the ‘valley of death’ funding gap.The program believes, according to Illinois Ventures’ website, “proof of concept funding provides a bridge between basic scientific research and marketplace entry and helps to "de-risk" a technology and increase its potential for commercialization. The program will help spur translation of the research conducted at Illinois’ universities and federal labs into the market to make an impact on the state’s economy. The selection committee for the program is made up of industry experts and venture capitalists from Illinois and across the country, exposing university innovations to new audiences and improving the connections between university innovation and corporations and venture capitalists across the state and country.” Dr. Klein and his lab are among the first recipients of this award.
The Klein lab’s award was also featured in Crain’s Chicago Business magazine. Crain's Chicago Business is a business newspaper published on a weekly basis.
6 February 2015